News

Vaccination Update: COVID-19 Vaccines Narrow Down The Chances Of Serious Illness By 80% In Over 80s.

COVID-19 Vaccines Narrow Down The Chances Of Serious Illness By 80% In Over 80s.

An analysis in England states that a single jab of both oxford-AstraZeneca and Pfizer-BioNTech vaccine reduces the risk of needing hospital treatment by more than 80%. The public health England data showed the effect kicked in three to four weeks after vaccination. This was based on people aged above 80 who were first to receive the jab. On the other hand, government scientists hailed the results but stressed that two doses were needed for the best protection. This comes after similar findings were published by Scottish health authorities very recently in which they hailed as “Spectacular.”

COVID-19 Vaccines Narrow Down The Chances Of Serious Illness By 80% In Over 80s.

After the vaccination of old age, people for the question of who is next is answered by the Joint Committee on Vaccination and Immunization (JCVI) by saying the next people to be offered the jab, from around mid-April and the process will be in descending order of age. The committee decided against giving priority to people in particular jobs, such as teaching because they said this would be more complex to deliver and might slow down the vaccine program. It also urged some groups who are at higher risk of needing hospital treatment from Covid to take up the offer of vaccination promptly:

COVID-19 Vaccines Narrow Down The Chances Of Serious Illness By 80% In Over 80s.

The Health Secretary Matt Hancock told a Downing Street briefing on Monday the latest vaccine results were “very strong”. He also said that “They may also help to explain why the number of Covid admissions to intensive care units among people over 80 in the UK have dropped to single figures in the last couple of weeks.”

On the other hand, while speaking at the news conference, England’s deputy chief medical officer – Prof Jonathan Van-Tam – said the data offered a glimpse of how the vaccine program “is going to hopefully take us into a very different world in the next few months”. But he said it was “absolutely critical” that second doses “are still part of the course of immunization against Covid-19 and no less important”. Prof Van-Tam stressed there was a “significant likelihood” that the second dose of a vaccine would “mature your immune response, possibly make it broader and almost certainly make it longer than it would otherwise be concerning a first dose only.” More than 20 million people in the UK have had their first dose of a vaccine – over a third of the adult population. Whereas another 104 deaths within 28 days of a positive coronavirus have been reported in the UK, and a further 5,455 new cases, according to the latest counts.

The PHE data, which has not been peer-reviewed, also suggested the Pfizer vaccine, which started being rolled out a month before the AstraZeneca vaccine, leads to an 83% reduction in deaths from Covid. This was based on people over the age of 80 who had died.

The data also exhibited vaccination cuts the chances of people over 70 developing any Covid symptoms by around 60%, three weeks after an initial dose. Prof Van-Tam opinioned that the decision to give the AstraZeneca vaccine to older people was “clearly vindicated.”

It was also reported recently that some European nations have refused to give it to them over 65s because data from the trials was mainly on its effect among younger adults. Prof Van-Tam said the judgment made by the UK authorities was that it was simply “not plausible” the vaccine would only work on younger adults. He said other countries would doubtless be “very interested” in the data coming out of the UK.

Public Health England’s head of immunization Dr. Mary Ramsay marked her opinion there was growing evidence that the vaccines were working to reduce infections and save lives.

She also said that “While there remains much more data to follow, this is encouraging, and we are increasingly confident that vaccines are making a real difference.” 

As a matter of fact, there is still more evidence is needed to know how well the vaccines protect against the Brazil variant that has recently been identified in the UK. This variant has a mutation – E484 – that could reduce some of the effectiveness of the vaccines.

On Sunday it was announced that six new variants reported cases whereas three in England and three in Scotland which had been found through testing. Health officials have been only able to contact one of these people. The whereabouts of the remaining individual are unknown as they did not complete their test registration card. It has prompted an appeal for anyone without a result from a test on 12 or 13 February to come forward immediately by calling 119.

The health secretary has explained the delay in imposing quarantine hotel measures on travelers to the UK put lives at risk, as officials continue to seek the individual. Mr. Hancock said there was “no evidence” the infected person had not followed home quarantine rules. Earlier this month Mr. Prime Minister has said the UK has “one of the toughest border regimes anywhere in the world for stopping people coming into this country who may have variants of concern”.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top